AU5918799A - Recombinant reduced valency carbohydrate binding ligands - Google Patents

Recombinant reduced valency carbohydrate binding ligands

Info

Publication number
AU5918799A
AU5918799A AU59187/99A AU5918799A AU5918799A AU 5918799 A AU5918799 A AU 5918799A AU 59187/99 A AU59187/99 A AU 59187/99A AU 5918799 A AU5918799 A AU 5918799A AU 5918799 A AU5918799 A AU 5918799A
Authority
AU
Australia
Prior art keywords
binding ligands
carbohydrate binding
reduced valency
valency carbohydrate
recombinant reduced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59187/99A
Inventor
David E. Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sensor Technologies Inc
Original Assignee
Sensor Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sensor Technologies Inc filed Critical Sensor Technologies Inc
Publication of AU5918799A publication Critical patent/AU5918799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AU59187/99A 1998-09-11 1999-09-10 Recombinant reduced valency carbohydrate binding ligands Abandoned AU5918799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9989598P 1998-09-11 1998-09-11
US60099895 1998-09-11
PCT/US1999/020853 WO2000016099A1 (en) 1998-09-11 1999-09-10 Recombinant reduced valency carbohydrate binding ligands

Publications (1)

Publication Number Publication Date
AU5918799A true AU5918799A (en) 2000-04-03

Family

ID=22277141

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59187/99A Abandoned AU5918799A (en) 1998-09-11 1999-09-10 Recombinant reduced valency carbohydrate binding ligands

Country Status (2)

Country Link
AU (1) AU5918799A (en)
WO (1) WO2000016099A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544193B2 (en) 1996-09-04 2003-04-08 Marcio Marc Abreu Noninvasive measurement of chemical substances
DE60017755T2 (en) 1999-08-26 2005-06-30 Novartis Ag AUGENANALYTFÜHLER
US9848815B2 (en) 2002-04-22 2017-12-26 Geelux Holdings, Ltd. Apparatus and method for measuring biologic parameters
US8849379B2 (en) 2002-04-22 2014-09-30 Geelux Holdings, Ltd. Apparatus and method for measuring biologic parameters
EP1565100A4 (en) 2002-04-22 2008-11-19 Marcio Marc Abreu Apparatus and method for measuring biologic parameters
US8328420B2 (en) 2003-04-22 2012-12-11 Marcio Marc Abreu Apparatus and method for measuring biologic parameters
GB0327179D0 (en) 2003-11-21 2003-12-24 Uws Ventures Ltd Purification method
US10227063B2 (en) 2004-02-26 2019-03-12 Geelux Holdings, Ltd. Method and apparatus for biological evaluation
GB0426822D0 (en) * 2004-12-07 2005-01-12 Precisense As Sensor for detection of glucose
GB0426823D0 (en) 2004-12-07 2005-01-12 Precisense As Sensor for detection of glucose
CA2847144A1 (en) 2005-10-24 2007-05-03 Marcio Marc Abreu Apparatus and method for measuring biologic parameters
WO2011075575A1 (en) * 2009-12-17 2011-06-23 Bayer Healthcare Llc Transdermal systems, devices, and methods to optically analyze an analyte
CA2927036A1 (en) 2013-10-11 2015-04-16 Marcio Marc Abreu Method and apparatus for biological evaluation
JP2017505657A (en) 2014-01-10 2017-02-23 マーシオ マーク アブリュー Device for monitoring and providing treatment in the Abreu brain tunnel
WO2015106137A1 (en) 2014-01-10 2015-07-16 Marcio Marc Abreu Device for measuring the infrared output of the abreu brain thermal tunnel
CN106163463A (en) 2014-01-22 2016-11-23 马尔西奥·马克·阿布雷乌 It is configured to the device processed in ABREU brain fever passage offer
AU2016228998A1 (en) 2015-03-10 2017-09-28 Marcio Marc Abreu Devices, apparatuses, systems, and methods for measuring temperature of an ABTT terminus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342789A (en) * 1989-12-14 1994-08-30 Sensor Technologies, Inc. Method and device for detecting and quantifying glucose in body fluids
US5628310A (en) * 1995-05-19 1997-05-13 Joseph R. Lakowicz Method and apparatus to perform trans-cutaneous analyte monitoring

Also Published As

Publication number Publication date
WO2000016099A9 (en) 2000-08-10
WO2000016099A1 (en) 2000-03-23

Similar Documents

Publication Publication Date Title
AU2375395A (en) Bidentate phosphine ligand
AU5918799A (en) Recombinant reduced valency carbohydrate binding ligands
GB9711237D0 (en) Organomettallic Complexes
AUPO566297A0 (en) Calcium phosphopeptide complexes
AU5587898A (en) Snowboard binding
AU6268599A (en) Quad-layer gmr sandwich
EP0790676A3 (en) Lever type connector
AU6015099A (en) Sandwich construction
AU7113896A (en) Tumor derived carbohydrate binding protein
AUPP790898A0 (en) Renal dialysis
AUPP298498A0 (en) Matrix binding factor
AU8596498A (en) Annexin binding protein
AU2190801A (en) Binding protein
AU5382200A (en) Muc1 ligands
AU9650398A (en) Piperazine-cyclodextrin complexes
AU3640397A (en) Ob protein binding protein
AU1645899A (en) Filter arrangement
AU3290197A (en) Halopropargyl inclusion complexes
AU1741000A (en) Recombinant factor viii binding peptides
AU8129798A (en) Filter
AU4586497A (en) Calcium-integrin binding protein
AU6000498A (en) Compounds for use in adept
AU6509998A (en) Virtual studio
AUPO711697A0 (en) Line filter
AU2435295A (en) Binding assembly

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase